candesartan cilexetil has been researched along with Arteriosclerosis in 5 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan cilexetil treatment reduced neointimal formation both in allografts (Qint 30." | 5.31 | Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in rat. ( Fellström, B; Larsson, E; Zezina, L, 2001) |
| "Candesartan cilexetil treatment reduced neointimal formation both in allografts (Qint 30." | 1.31 | Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in rat. ( Fellström, B; Larsson, E; Zezina, L, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariff, B | 1 |
| Stanton, A | 1 |
| Barratt, D | 1 |
| Augst, A | 1 |
| Glor, F | 1 |
| Poulter, N | 1 |
| Sever, P | 1 |
| Xu, Y | 1 |
| Hughes, A | 1 |
| Thom, SA | 1 |
| Johnstone, MT | 1 |
| Perez, AS | 1 |
| Nasser, I | 1 |
| Stewart, R | 1 |
| Vaidya, A | 1 |
| Al Ammary, F | 1 |
| Schmidt, B | 1 |
| Horowitz, G | 1 |
| Dolgoff, J | 1 |
| Hamilton, J | 1 |
| Quist, WC | 1 |
| Rosei, EA | 1 |
| Rizzoni, D | 1 |
| Muiesan, ML | 1 |
| Sleiman, I | 1 |
| Salvetti, M | 1 |
| Monteduro, C | 1 |
| Porteri, E | 1 |
| Kino, H | 1 |
| Hama, J | 1 |
| Takenaka, T | 1 |
| Sugimura, K | 1 |
| Kamoi, K | 1 |
| Shimada, S | 1 |
| Yamamoto, Y | 1 |
| Nagata, S | 1 |
| Horiuchi, M | 1 |
| Katori, R | 1 |
| Zezina, L | 1 |
| Larsson, E | 1 |
| Fellström, B | 1 |
2 trials available for candesartan cilexetil and Arteriosclerosis
| Article | Year |
|---|---|
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographics.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Antihypertensive Agents | 2002 |
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inh | 2005 |
3 other studies available for candesartan cilexetil and Arteriosclerosis
| Article | Year |
|---|---|
Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Arteriosclerosis; Benzimid | 2004 |
Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arteriosclerosis; Benzimidazoles | 1994 |
Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in rat.
Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dru | 2001 |